How Bipolar Disorder and Schizophrenia Differ

They can have overlapping features

Table of Contents
View All
Table of Contents

Bipolar disorder and schizophrenia share similar aspects, but schizophrenia is characterized by continuous or relapsing episodes of psychosis, while bipolar disorder is a mood disorder that can sometimes manifest with psychotic symptoms. Because they sometimes present similarly, these disorders may be mistaken for each other.

Brief definitions of these disorders are as follows:

  • Bipolar disorder is a mood disorder characterized by episodes of depression and episodes of mania or hypomania.
  • Schizophrenia is a psychiatric condition characterized by recurrent hallucinations (false sensations) and/or delusions (false beliefs), as well as impaired functioning.
  • Schizoaffective disorder is a psychiatric condition characterized by episodes of psychosis along with and independent from mood disorder symptoms. A depressive type of schizoaffective disorder may be diagnosed when major depression occurs, and a bipolar type of schizoaffective disorder is characterized by bouts of mania.

Laura Porter / Verywell


If you have bipolar disorder, schizophrenia, or schizoaffective disorder, you may recognize many of your symptoms in descriptions of these conditions. However, there are variations in the symptoms you might experience.

The symptoms of schizophrenia and bipolar disorder can vary by person; no two cases are exactly alike.

Bipolar Disorder

The symptoms of bipolar disorder include clinically significant episodes of depression and hypomania and/or mania.

Symptoms of depression in bipolar disorder include:

  • Sadness
  • Lack of interest in things previously enjoyed
  • Feelings of worthlessness
  • Changes in appetite
  • A sense of hopelessness and thoughts of suicide

Symptoms of mania in bipolar disorder include:

  • Restlessness, inability to fall asleep
  • Racing thoughts
  • Elevated or irritable moods
  • Unrealistic planning
  • Overestimation of personal abilities
  • Risk-taking

Mixed affective episodes occur when mania and depression occur at the same time. For example, a person may feel hopeless and could also have racing thoughts or risk-taking behavior.  

Bipolar disorder can lead to effects such as overwhelming paranoia or an exaggerated sense of self importance with an extreme detachment from reality that may present similarly to schizophrenia. 


Schizophrenia is characterized by dissociation from reality, in the form of hallucinations, delusions, or disorganization. Negative symptoms, which include behaviors of impaired emotional expression and functioning, are a major component of this disorder as well. And cognitive symptoms, such as memory impairment, can affect a person’s ability to take care of themselves.  

Positive symptoms:

  • Delusions and/or hallucinations
  • Paranoia
  • Agitation
  • Disorganized speech
  • Disorganized behavior

Negative symptoms:

  • Apathy (lack of interest)
  • Withdrawal from others
  • Isolation
  • Lack of emotional expression
  • Excessive sleeping

Cognitive deficits:

  • Diminished attention
  • Impaired memory and learning
  • Difficulty thinking and problem solving

Schizoaffective disorder includes the symptoms of schizophrenia, but a person who has schizoaffective disorder will also experience prolonged and persistent mood symptoms.

Schizophrenia is characterized by psychosis. By contrast, only between 20% and 50% of people with bipolar disorder will experience a psychotic episode.


Bipolar disorder and schizophrenia are each believed to stem from genetic, biological, and environmental causes, although there are key differences.

Bipolar disorder affects approximately 2% of the population. Schizophrenia affects approximately 1% of the population. Schizoaffective disorder is much less common than either bipolar disorder or schizophrenia, with an estimated prevalence of approximately 0.3% of the population.

The average age of onset of symptoms for each of these conditions is in a person’s early 20s. The range of symptom onset is wider for bipolar disorder.


There appears to be a strong genetic component contributing to the development of both schizophrenia and bipolar disorder.

Twin studies show that monozygotic (identical) twins are more likely to share a diagnosis of schizophrenia than dizygotic (fraternal, not identical) twins. This also correlates with alterations in the connectivity between certain structures of the brain that researchers believe to be strongly influenced by genetics. 

Bipolar disorder is impacted by genetic factors, and twin studies show a higher correlation of the diagnosis between identical twins than nonidentical twins. This is associated with lower volume in certain areas of the brain.


Prenatal issues are associated with the development of schizophrenia, but have not been found to be firmly linked to the development of bipolar disorder.

Maternal emotional stress, infections, birth complications, low oxygen level, and fetal distress are associated with an increased risk of subsequent development of schizophrenia.


A person’s community and environment play a role in the risk of bipolar disorder, as well as schizophrenia. Experts suggest that environmental factors do not cause these conditions, but that they can contribute to symptoms in people who are genetically vulnerable.

Researchers propose that exposure to substance abuse and/or excessive stress can induce metabolic changes in the body that amplify expression of the genetic factors that contribute to these disorders—possibly precipitating the brain changes that lead to the clinical effects.

Contributing environmental factors include childhood trauma, social isolation, and substance abuse.

Urbanicity is one of the factors that has been associated with these conditions. It has been suggested that pollution, noise, disrupted sleep, and social stress could underlie this association.


Bipolar disorder, schizophrenia, and schizoaffective disorder are each diagnosed based on criteria outlined in the "Diagnostic and Statistical Manual of Disorder of Mental Disorders" (DSM-5), which is the disease classification system used by mental health professionals.

Other potential causes of the symptoms, such as drugs, brain injury, or a major medical illness, such as encephalitis (brain inflammation) must be ruled out for a person to be diagnosed with any of these conditions.

Bipolar Disorder

Bipolar disorder diagnosis requires the presence of at least one manic or hypomanic episode and generally at least one major depressive episode.


For a diagnosis of schizophrenia, a person must have symptoms for at least six consecutive months.

Criteria includes at least one or two of the following:

  • Delusions
  • Hallucinations
  • Disorganized speech

If only one of the above is present, a person must also have:

  • Severely disorganized behavior
  • Negative symptoms, such as catatonic behavior, apathy, lack of expression

For a diagnosis of schizophrenia, the symptoms must be associated with a deterioration in self-care, relationships, or work. 

A diagnosis of schizoaffective disorder requires the presence of symptoms of schizophrenia. The mood symptoms must be present most of the time, but the symptoms of psychosis must be present for more than two weeks without mood symptoms.

There has been some debate as to whether or not schizoaffective disorder should be its own diagnosis. Some say it should be a category of schizophrenia, severe depression, or bipolar disorder.


Bipolar disorder and schizophrenia can be managed with medical interventions, but these conditions are not curable. Counseling is also an important component of the management of these conditions.

Treatments for schizophrenia include antipsychotic medications, which are taken daily to prevent symptoms. Treatments for bipolar disorder include lithium and other mood stabilizers, usually along with antipsychotic medications.

Certain types of psychotherapy can be beneficial in schizophrenia and bipolar disorder.

Treatment with electroconvulsive (ECT) therapy can be beneficial for those with depressive episodes and/or manic episodes in bipolar disorder, and it is considered one of the treatment options for managing the condition.

ECT has been studied as a potential therapy for the treatment of schizophrenia, and it can relieve some symptoms in the short term, but it is not considered a routine treatment for schizophrenia.


Schizophrenia and bipolar disorder are both lifelong conditions, but treatment can improve a person’s prognosis. These conditions can increase the risk of substance abuse and suicide.

Some estimates are that between 4% to 19% of people with bipolar disorder die by suicide, a rate that is 10 to 30 times higher than the general population. A 2020 study found that the suicide rate for people with schizophrenia spectrum disorders is over 20 times higher than for the general population.

These disorders are also associated with a risk of health problems due to neglecting one’s own physical symptoms and a lack of motivation and ability to get medical attention as well as the impact of some of the treatments.

These conditions can worsen acutely, with severe dissociation from reality, thoughts of suicide, and/or self-harm. Episodes of acute worsening may require inpatient hospitalization.

A Word From Verywell

Living with bipolar disorder or schizophrenia is challenging for the person who has the condition, and for their friends and family. Both conditions are characterized by severe distress and relationship difficulties.

The person who is experiencing the symptoms may have a lack of insight, which can interfere with communication, diagnosis, and treatment. However, once a diagnosis is made and treatment is initiated, symptoms can often be well-controlled, with a corresponding improvement in quality of life.

Maintaining a consistent routine, reducing stress, having a healthy diet, and staying active can all contribute to a better overall outcome.

13 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Dunayevich E, Keck PE Jr. Prevalence and description of psychotic features in bipolar mania. Curr Psychiatry Rep. 2000 Aug;2(4):286-90. doi:10.1007/s11920-000-0069-4

  2. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiativeArch Gen Psychiatry. 2011;68(3):241-251. doi:10.1001/archgenpsychiatry.2011.12

  3. Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: overview and treatment optionsP T. 2014;39(9):638-645.

  4. Wy TJP, Saadabadi A. Schizoaffective disorder. StatPearls.

  5. Cao H, Ingvar M, Hultman CM, Cannon T. Evidence for cerebello-thalamo-cortical hyperconnectivity as a heritable trait for schizophrenia. Transl Psychiatry. 2019 Aug 20;9(1):192. doi:10.1038/s41398-019-0531-5

  6. Squarcina L, Fagnani C, Bellani M, Altamura CA, Brambilla P. Twin studies for the investigation of the relationships between genetic factors and brain abnormalities in bipolar disorder. Epidemiol Psychiatr Sci. 2016 Dec;25(6):515-520. doi:10.1017/S2045796016000615

  7. Stilo SA, Murray RM. Non-genetic factors in schizophrenia. Curr Psychiatry Rep. 2019 Sep 14;21(10):100. doi:10.1007/s11920-019-1091-3

  8. Misiak B, Stramecki F, Gawęda Ł, Prochwicz K, Sąsiadek MM, Moustafa AA, Frydecka D. Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: a systematic review. Mol Neurobiol. 2018 Jun;55(6):5075-5100. doi:10.1007/s12035-017-0708-y

  9. Laws KR, Darlington N, Kondel TK, McKenna PJ, Jauhar S. Cognitive Behavioural Therapy for schizophrenia - outcomes for functioning, distress and quality of life: a meta-analysis. BMC Psychol. 2018 Jul 17;6(1):32. doi:10.1186/s40359-018-0243-2

  10. Perugi G, Medda P, Toni C, Mariani MG, Socci C, Mauri M. The role of electroconvulsive therapy (ECT) in bipolar disorder: effectiveness in 522 patients with bipolar depression, mixed-state, mania, and catatonic featuresCurr Neuropharmacol. 2017;15(3):359-371. doi:10.2174/1570159X14666161017233642

  11. Sinclair DJM, Zhao S, Qi F, Nyakyoma K, Kwong JSW, Adams CE. Electroconvulsive therapy for treatment-resistant schizophrenia. Schizophr Bull. 2019 Jun 18;45(4):730-732. doi:10.1093/schbul/sbz037

  12. Dome P, Rihmer Z, Gonda X. Suicide risk in bipolar disorder: A brief review. Medicina (Kaunas). 2019;55(8):403. doi:10.3390/medicina55080403

  13. Zaheer J, Olfson M, Mallia E, Lam JSH, de Oliveira C, Rudoler D, Carvalho AF, Jacob BJ, Juda A, Kurdyak P. Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada. Schizophr Res. 2020 Aug;222:382-388. doi:10.1016/j.schres.2020.04.025

By Heidi Moawad, MD
Heidi Moawad is a neurologist and expert in the field of brain health and neurological disorders. Dr. Moawad regularly writes and edits health and career content for medical books and publications.